Oracle Introduces AI Agents to Enhance Clinical Trial Operations
Oracle has launched Oracle Life Sciences AI Agents, an AI-assisted coordination layer designed to streamline clinical trial operations. These agents are initially focused on portfolio monitoring, trial planning, and trial conduct. They integrate insights from Oracle Life Sciences applications and supported third-party data sources to identify operational issues, recommend actions, and coordinate responses across various clinical development workflows. While the AI agents propose actions, human review and approval are required before execution, ensuring oversight. Seema Verma, executive vice president and general manager of Oracle Health and Life Sciences, stated that the goal is to monitor performance, identify emerging risks, and coordinate responses throughout the trial lifecycle. The offering combines Oracle’s Life Sciences applications, AI capabilities, connected data services, and cloud infrastructure, fitting into existing clinical trial systems like Oracle Life Sciences CTMS.